Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02416206 · FLOW

Participant flow

High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma · Source last updated 2023-05-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Bendaumustine, Etoposide, Cytrabine and Melphalan in autologous transplant for multiple myeloma BeEAM: BeEAM
    id
    FG000
    title
    BeEAM
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        65
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        65
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Bendaumustine, Etoposide, Cytrabine and Melphalan in autologous transplant for multiple myeloma BeEAM: BeEAM
    id
    FG000
    title
    BeEAM
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        65
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        65
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice